Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 1.00 |
| ▸ | CA9 | Q16790 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.86 |
| ▸ | MEN1 | O00255 | 3/20 | 0.86 |
| ▸ | GAA | P10253 | 2/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.74 |
| ▸ | PKM | P14618 | 1/20 | 0.74 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.73 |
| ▸ | IL1RN | P18510 | 1/20 | 0.73 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.73 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.73 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.68 |
| ▸ | GFER | P55789 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19119164 | 1.00 | CA12 (1.00) | CA12CA9CA1CA2KMT2A | |
| SCHEMBL27824001 | 0.98 | CA12 (0.96) | CA12CA9CA1CA2KMT2A | |
| Water SCHEMBL3944291 | 0.98 | CA12 (0.96) | CA12CA9CA1CA2KMT2A | |
| SCHEMBL28689444 | 0.98 | CA12 (0.96) | CA12CA9CA1CA2KMT2A | |
| SCHEMBL13167620 | 0.94 | CA12 (0.89) | CA12CA9CA1CA2KMT2A | |
| SCHEMBL9479370 | 0.93 | KMT2A (1.00) | CA12CA9CA1CA2KMT2A | |
| SCHEMBL1952693 | 0.93 | KMT2A (1.00) | CA12CA9CA1CA2KMT2A | |
| SCHEMBL92717 | 0.93 | KMT2A (1.00) | CA12CA9CA1CA2KMT2A | |
| SCHEMBL806766 | 0.92 | CA12 (0.85) | CA12CA9CA1CA2KMT2A | |
| Ammonia Solution, Strong SCHEMBL15741206 | 0.91 | KMT2A (0.97) | CA12CA9CA1CA2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 819 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111393304-B | Method for preparing p-phenylenediamine from aniline | 江苏扬农化工集团有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-110526832-B | Method for preparing polysubstituted alicyclic compound | 浙江师范大学 | 2022-06-10 | — | — | CN | claimed |
| CN-114075151-A | 3,4-2H-1, 3-oxazine-2-ketone compounds and preparation method thereof | 复旦大学 | 2022-02-22 | — | — | CN | claimed |
| CN-111393304-A | Method for preparing p-phenylenediamine from aniline | 江苏扬农化工集团有限公司 | 2020-07-10 | — | — | CN | claimed |
| EP-2998359-B1 | METHOD FOR IMPROVING THE ELECTRICAL-INSULATING PROPERTY AND THE FOGGING RESISTANCE OF A POLYESTER RESIN COMPOSITION | ADEKA CORP (JP) | 2019-08-21 | — | — | EP | claimed |
| EP-3075784-B1 | PROCESS FOR PRODUCING MASTERBATCH | ADEKA CORP (JP) | 2018-10-03 | — | — | EP | claimed |
| EP-2484725-B1 | POLYESTER RESIN COMPOSITION, POLYESTER FIBER, POLYESTER RESIN MOLDED ARTICLE, AND PROCESS FOR PRODUCTION OF NUCLEATING AGENT FOR POLYESTER RESIN | ADEKA CORP (JP) | 2017-07-19 | — | — | EP | claimed |
| EP-2934142-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | Dow AgroSciences LLC (US) | 2015-10-28 | — | — | EP | claimed |
| WO-2014120355-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2014-08-07 | — | — | WO | claimed |
| US-20140001672-A1 | POLYESTER RESIN COMPOSITION, POLYESTER FIBER, POLYESTER RESIN MOLDED ARTICLE, AND PROCESS FOR PRODUCTION OF NUCLEATING AGENT FOR POLYESTER RESIN | ADEKA CORPORATION (JP) | 2014-01-02 | — | — | US | claimed |
| US-20110313000-A1 | CCR9 INHIBITORS AND METHODS OF USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2011-12-22 | — | — | US | claimed |
| US-20100280074-A1 | CCR9 INHIBITORS AND METHODS OF USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-11-04 | — | — | US | claimed |
| US-20090054495-A1 | CCR9 inhibitors and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. | 2009-02-26 | — | — | US | claimed |
| US-20080078293-A1 | REMOVING METHOD AND APPARATUS FOR HIGH-MELTING POINT COMPOUND, SOLVENT RECOVERING METHOD AND SOLVENT RECOVERING APPARATUS | FUJIFILM CORPORATION (JP) | 2008-04-03 | — | — | US | claimed |
| US-20060238684-A1 | Liquid crystal panel and liquid crystal display apparatus | NITTO DENKO CORPORATION (JP) | 2006-10-26 | — | — | US | claimed |
| US-6335306-B1 | SUBBING LAYER OF COLOR DEVELOPABILITY REDUCING AGENT AND IMAGE-FORMING LAYER OF COLORLESS OR LIGHT-COLORED DYE PRECURSOR AND COLOR-DEVELOPER; HEATED AND FIXED AT HIGH TEMPERATURE, IMAGE HAS HIGH SOLVENT RESISTANCE, IMAGE CLARITY | OJI PAPER CO., LTD. (JP) | 2002-01-01 | — | — | US | claimed |
| US-5256493-A | Crosslinking agent for heat curable coatings | CYTEC TECHNOLOGY CORP. | 1993-10-26 | — | — | US | claimed |
| US-4968737-A | Molding compounds comprising a thermoplastically processible aromatic polyamide | HUELS AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | claimed |
| US-4929530-A | OXIDATIVE LEUCO DYES, PHOTO-OXIDIZERS, REDUCING AGENTS, ORGANIC SULFONAMIDES AND PHENOLIC COMPONENTS; EXPOSING TO LIGHT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-29 | — | — | US | claimed |
| EP-0349204-A2 | Use and regeneration of reagents using coupled reactions and permselective barriers | BEND RESEARCH, INC. (US) | 1990-01-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313000-A1 | CCR9 INHIBITORS AND METHODS OF USE THEREOF | CCR9, CCR1, CCR4 | CA12 1413/4885CA9 85/4885CA1 1331/4885 |
| US-20100280074-A1 | CCR9 INHIBITORS AND METHODS OF USE THEREOF | CCR9, CCR1, CCR4 | CA12 1413/4885CA9 85/4885CA1 1331/4885 |
| US-20090054495-A1 | CCR9 inhibitors and methods of use thereof | CCR9, CCR1, CCR4 | CA12 1413/4885CA9 85/4885CA1 1331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.